BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12072823)

  • 1. [Dysfunction of the magnocellular pathway in Alzheimer's disease].
    Jacob B; Hache JC; Pasquier F
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):555-64. PubMed ID: 12072823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vision in Alzheimer's disease].
    Ceccaldi M
    Rev Neurol (Paris); 1996; 152(6-7):441-6. PubMed ID: 8944240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?
    Katz B; Rimmer S; Iragui V; Katzman R
    Ann Neurol; 1989 Aug; 26(2):221-5. PubMed ID: 2774509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiologic analyses of low- and high-level visual processing in Alzheimer disease.
    Fernandez R; Kavcic V; Duffy CJ
    Neurology; 2007 Jun; 68(24):2066-76. PubMed ID: 17562827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optometric management of patients with Alzheimer's disease.
    Baker DR; Mendez MF; Townsend JC; Ilsen PF; Bright DC
    J Am Optom Assoc; 1997 Aug; 68(8):483-94. PubMed ID: 9279048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
    McKendrick AM; Sampson GP
    Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual dysfunction in Alzheimer's disease: relation to normal aging.
    Cronin-Golomb A; Corkin S; Rizzo JF; Cohen J; Growdon JH; Banks KS
    Ann Neurol; 1991 Jan; 29(1):41-52. PubMed ID: 1996878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and the eye.
    Wolin MJ
    J S C Med Assoc; 1994 Nov; 90(11):534-8. PubMed ID: 7853856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways.
    Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC
    Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual-spatial deficits expalin visual symptoms in Alzheimer's disease.
    Butter CM; Trobe JD; Foster NL; Berent S
    Am J Ophthalmol; 1996 Jul; 122(1):97-105. PubMed ID: 8659604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of parvocellular and magnocellular pathways on visual impairment in apperceptive agnosia?
    Hildebrandt H; Schütze C; Ebke M; Spang K
    Neurocase; 2004 Jun; 10(3):207-14. PubMed ID: 15788258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.
    Mentis MJ; Horwitz B; Grady CL; Alexander GE; VanMeter JW; Maisog JM; Pietrini P; Schapiro MB; Rapoport SI
    Am J Psychiatry; 1996 Jan; 153(1):32-40. PubMed ID: 8540589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motion integration deficits are independent of magnocellular impairment in Parkinson's disease.
    Castelo-Branco M; Mendes M; Silva F; Massano J; Januário G; Januário C; Freire A
    Neuropsychologia; 2009 Jan; 47(2):314-20. PubMed ID: 18822307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast sensitivity changes due to glaucoma and normal aging: low-spatial-frequency losses in both magnocellular and parvocellular pathways.
    McKendrick AM; Sampson GP; Walland MJ; Badcock DR
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2115-22. PubMed ID: 17460269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual-evoked response, pattern electroretinogram, and psychophysical magnocellular thresholds in glaucoma, optic atrophy, and dyslexia.
    Vaegan ; Hollows FC
    Optom Vis Sci; 2006 Jul; 83(7):486-98. PubMed ID: 16840873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological and perceptual correlates of navigational impairment in Alzheimer's disease.
    Kavcic V; Fernandez R; Logan D; Duffy CJ
    Brain; 2006 Mar; 129(Pt 3):736-46. PubMed ID: 16461482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.
    Sartucci F; Borghetti D; Bocci T; Murri L; Orsini P; Porciatti V; Origlia N; Domenici L
    Brain Res Bull; 2010 May; 82(3-4):169-76. PubMed ID: 20385208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
    Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvocellular and magnocellular contributions to the initial generators of the visual evoked potential: high-density electrical mapping of the "C1" component.
    Foxe JJ; Strugstad EC; Sehatpour P; Molholm S; Pasieka W; Schroeder CE; McCourt ME
    Brain Topogr; 2008 Sep; 21(1):11-21. PubMed ID: 18784997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.